Developer docs
API playgroundTry for free, no card

Search company profiles

Fiberlab

Full company profile

uuid002dqdu

Namestring
Fiberlab
Legal namestring
Fiberlab Biotech
Websiteurl
fiberlab.io
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Fiberlab Biotech, founded in 2016 and privately held, is a U.S.-based manufacturer of pharmaceutical-grade cannabinoid acid isolates and condition-specific compound formulas, operating with 1–10 employees and a registered presence in Austin, TX. The company's core technology is a proprietary cryogenic (non-CO2) closed-loop extraction process combined with a six-step manufacturing workflow — extraction, winterization, decarboxylation, isolation, purification, and quality verification — designed to preserve cannabinoid acid integrity and achieve a stated 99.9%+ purity standard with zero residual solvents. All products undergo multi-method third-party verification, including HPLC-UV/LC-MS, GC-MS Headspace, ICP-MS, qPCR/Culture, and LC-MS/MS testing, with 100% COA coverage across the catalog.

The product portfolio is organized around five acid isolates (THCA, CBDA, CBGA, CBCA, CBNA) at 99.9%+ purity and four proprietary compound formulas — NeuroCalm (FC-N01), Serenity (FC-S02), Oncology Support (FC-O03), and Inflammation Protocol (FC-I04) — each blended for specific therapeutic indications including neurological disorders, chronic pain, PTSD, oncology support, and inflammation. Two delivery devices, a Cannabinoid Nasal Spray (10 mL, 100 doses) and a Cannabinoid Inhaler, extend the portfolio into rapid-onset pulmonary and intranasal administration.

Fiberlab generates revenue through physician-priced sales of its isolates, compound formulas, and delivery devices, distributed exclusively through a network of 6+ licensed compounding pharmacies across 4 states (AZ, CO, TN, TX). The go-to-market is sales-led and physician-directed, with inquiries routed through a clinical affairs team that provides same-day response to physicians and 1–5 business day response to pharmacies, patients, and researchers. Pricing is quote-based and not publicly disclosed; a 2026 strategic pivot and the launch of the CannapūrRx sub-brand signal an ongoing portfolio repositioning.

Short descriptiontext

Fiberlab Biotech is a U.S. manufacturer of pharmaceutical-grade cannabinoid acid isolates (THCA, CBDA, CBGA, CBCA, CBNA) at 99.9%+ purity and condition-specific compound formulas, distributed exclusively through licensed compounding pharmacies serving physician-directed clinical protocols.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical cannabinoid isolates, cannabinoid compound formulas, cryogenic extraction processing, compounding pharmacy supply, purity verified cannabinoids
Industry1 code
PRIMARYHLAIAJAO
Compounding Ingredient & API Distributors (Pharma Supply)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
NAICS code2 codes
  • Medicinal and Botanical Manufacturing325411
  • Pharmaceutical and Medicine Manufacturing3254
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Cannabinoid Manufacturing
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Pharmaceutical Cannabinoid Product Sales
TypeOne Time License
Description

Sale of pharmaceutical-grade cannabinoid isolates (THCA, CBDA, CBGA, CBCA, CBNA) and compound formulas through licensed compounding pharmacy partners. Physician pricing model with quote-based inquiry process.

fiberlab.io
2Clinical Consultation Services
TypeProfessional Services
Description

Clinical affairs team provides support for physicians, pharmacies, patients, and researchers. Response times vary by inquiry type: physicians receive same-day response, others within 1-5 business days.

fiberlab.io
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales, Infrastructure
Pricing details4 tiers
1Cannabinoid Nasal Spray - 10mL, 100 doses
ModelUnit PricingBilling cadencePay-as-you-go
Notes

99.9%+ Pure THC. Physician pricing available via inquiry. No artificial flavors, colors, or preservatives.

fiberlab.io
2Cannabinoid Inhaler - Pulmonary delivery
ModelUnit PricingBilling cadencePay-as-you-go
Notes

99.9%+ Pure THC. Physician pricing via inquiry. No combustion or solvents.

fiberlab.io
3Individual Cannabinoid Isolates - Crystalline powder
ModelUnit PricingBilling cadencePay-as-you-go
Notes

THCA, CBDA, CBGA, CBCA, CBNA isolates at 99.9%+ purity. Physician pricing via inquiry.

fiberlab.io
4Compound Formulas - Condition-specific blends
ModelUnit PricingBilling cadencePay-as-you-go
Notes

FC-N01 NeuroCalm, FC-S02 Serenity, FC-O03 Oncology Support, FC-I04 Inflammation Protocol. Physician pricing via inquiry.

fiberlab.io
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1CannapūrRx
Description

Pharmaceutical-grade cannabinoid brand offering isolates and compound formulas for clinical applications including neurological disorders, chronic pain, PTSD, oncology support, and inflammation.

fiberlab.io
Core offering1 text field

Fiberlab manufactures pharmaceutical-grade cannabinoid acid isolates (THCA, CBDA, CBGA, CBCA, CBNA) at 99.9%+ purity using a proprietary cryogenic non-CO2 extraction and six-step manufacturing process with multi-method third-party verification. The company also blends these isolates into four condition-specific compound formulas (NeuroCalm, Serenity, Oncology Support, Inflammation Protocol) and produces two delivery devices (nasal spray and pulmonary inhaler). All products are distributed exclusively through a physician-directed model via licensed compounding pharmacies across AZ, CO, TN, and TX.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 99.9%+ pharmaceutical purity achieved across all cannabinoid isolates
+3 more records
Product overview1 text field

Fiberlab Biotech offers a portfolio of pharmaceutical-grade cannabinoid acid products built around five core isolate types (THCA, CBDA, CBGA, CBCA, CBNA) at 99.9%+ purity, supplemented by four proprietary compound formulas (NeuroCalm, Serenity, Oncology Support, Inflammation Protocol) that blend multiple isolates for specific therapeutic indications. The company also manufactures two delivery devices — a nasal spray and an inhaler — designed for rapid-onset cannabinoid delivery. All products are manufactured using cryogenic extraction and are distributed exclusively through a network of licensed compounding pharmacies.

Product and service11 records
1THCA Isolate
CategoryCannabinoid Isolate
Description

Tetrahydrocannabinolic acid in its purest pharmaceutical form — a 99.9%+ pure crystalline powder isolate with neuroprotective, anti-inflammatory, and anti-nausea properties, precisely dosed for clinical micro-dosing protocols. Sold to licensed physicians and compounding pharmacies.

2CBDA Isolate
CategoryCannabinoid Isolate
Description

Cannabidiolic acid isolate at 99.9%+ purity featuring serotonin-modulating properties, formulated for patients managing anxiety, PTSD, and treatment-related nausea. Sold to licensed physicians and compounding pharmacies.

3CBGA Isolate
CategoryCannabinoid Isolate
Description

The 'mother cannabinoid' isolate at 99.9%+ purity, the biosynthetic precursor to all major cannabinoids, supporting metabolic function and serving as the foundation of compound formulas, with antibacterial properties. Sold to licensed physicians and compounding pharmacies.

4CBCA Isolate
CategoryCannabinoid Isolate
Description

Cannabichromenic acid isolate at 99.9%+ purity with research-supported roles in neurogenesis and antimicrobial activity, a key component in neurological disorder protocols. Sold to licensed physicians and compounding pharmacies.

5CBNA Isolate
CategoryCannabinoid Isolate
Description

Cannabinolic acid isolate at 99.9%+ purity with sedative and appetite-stimulating properties, integral to oncology support and chronic pain compound formulas. Sold to licensed physicians and compounding pharmacies.

6NeuroCalm Formula (FC-N01)
CategoryCompound Formula
Description

A precision-blended compound formula combining THCA, CBCA, and CBGA isolates, targeting neuroprotection and pain modulation for patients with epilepsy, MS, Parkinson's, and neuropathic pain. Sold to physicians and compounding pharmacies.

7Serenity Formula (FC-S02)
CategoryCompound Formula
Description

Compound formula combining serotonin-modulating CBDA with calming CBNA, designed for patients navigating PTSD and anxiety disorders. Sold to physicians and compounding pharmacies.

8Oncology Support Formula (FC-O03)
CategoryCompound Formula
Description

A comprehensive adjunct formula combining THCA, CBDA, CBNA, and CBGA for patients in active cancer treatment, addressing nausea, appetite loss, pain, and inflammation with a full-spectrum cannabinoid acid blend. Sold to physicians and compounding pharmacies.

9Inflammation Protocol (FC-I04)
CategoryCompound Formula
Description

Targeted anti-inflammatory formula combining THCA, CBCA, and CBGA for systemic and localized inflammation, suitable for autoimmune conditions, arthritis, and post-surgical recovery. Sold to physicians and compounding pharmacies.

10Cannabinoid Nasal Spray
CategoryDelivery Device
Description

Advanced nasal delivery device providing 99.9%+ pure THC for rapid systemic absorption with precision dosing. 10 mL container providing 100 doses, no artificial flavors, colors, or preservatives, manufactured in GMP-certified facilities. Sold at physician pricing via inquiry.

11Cannabinoid Inhaler
CategoryDelivery Device
Description

Pulmonary delivery device providing pharmaceutical-grade 99.9%+ pure THC for targeted, fast-acting relief directly to the respiratory system with no combustion and no solvents. Sold at physician pricing via inquiry.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
1Austin Compounding Pharmacy
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Licensed compounding pharmacy in Austin, TX (1200 S Lamar Blvd). Dispenses THCA, CBDA, CBGA isolates and NeuroCalm, Serenity compound formulas. Accepting new patients. Hours: Mon-Fri 9am-6pm, Sat 10am-3pm.

fiberlab.io
2Houston Medical Compounders
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Licensed compounding pharmacy in Houston, TX (4500 Bissonnet St). Dispenses THCA, CBCA, CBNA isolates and Oncology Support, Inflammation Protocol formulas. Accepting new patients. Hours: Mon-Fri 8am-7pm, Sat 9am-4pm.

fiberlab.io
3Dallas Precision Pharmacy
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Licensed compounding pharmacy in Dallas, TX (6750 Hillcrest Ave). Dispenses CBDA, CBGA isolates and Serenity, NeuroCalm compound formulas. Accepting new patients. Hours: Mon-Fri 9am-5:30pm.

fiberlab.io
4Denver Integrative Compounding
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Licensed compounding pharmacy in Denver, CO (2100 E Colfax Ave). Dispenses all five isolates (THCA, CBDA, CBCA, CBNA, CBGA) and all four compound formulas. Accepting new patients. Hours: Mon-Fri 8:30am-6pm, Sat 10am-2pm.

fiberlab.io
5Phoenix Clinical Pharmacy
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Licensed compounding pharmacy in Phoenix, AZ (3300 N Central Ave). Dispenses THCA, CBGA isolates and Inflammation Protocol, Oncology Support formulas. Currently on waitlist. Hours: Mon-Fri 9am-6pm.

fiberlab.io
6Nashville Compounding Center
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Licensed compounding pharmacy in Nashville, TN (1800 Church St). Dispenses CBDA, CBNA isolates and Serenity, NeuroCalm compound formulas. Accepting new patients. Hours: Mon-Fri 9am-5pm.

fiberlab.io
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Charlotte's Web makes proprietary hemp-derived cannabinoid extracts targeting specific wellness and clinical use cases (sleep, calm, recovery) with branded product lines. Its vertically integrated cultivation-to-extract model and indication-focused product framing parallels Fiberlab's condition-specific compound formulas.

TypeBroad incumbent
Description

Aurora Cannabis operates a vertically integrated cannabinoid platform including GMP-certified production and medical cannabis distribution across multiple countries. Its broad medical/recreational footprint and GMP positioning make it a useful incumbent benchmark for Fiberlab's physician-channel ambitions.

TypeDirect peer
Description

Elixinol produces premium, third-party-tested hemp-derived CBD oils and capsules for both practitioner and consumer channels. Comparable to Fiberlab as a smaller, quality-focused cannabinoid producer targeting health professional and pharmacy distribution.

TypeDirect peer
Description

Medical Marijuana Inc. operates a portfolio of hemp-derived CBD and cannabinoid brands including HempMeds and Kannaway, with a strong physician/direct-selling channel orientation. Comparable to Fiberlab in the niche of smaller, specialist cannabinoid companies building branded product portfolios around clinical/endorsement positioning.

TypeBroad incumbent
Description

Canopy Growth produces both medical and consumer cannabinoid products through brands like Spectrum Therapeutics, with strong GMP and pharmaceutical partnerships. Comparable to Fiberlab as a broad incumbent serving a physician/cannabinoid-medicine channel at meaningful scale.

TypeDirect peer
Description

MediPharm Labs is a Canadian B2B manufacturer of pharmaceutical-grade cannabinoid APIs, extracts, and concentrates supplied to other producers and clinicians. Like Fiberlab, it focuses on wholesale purified inputs rather than retail consumer products, making it a directly comparable pharma-grade cannabinoid API supplier.

TypeBroad incumbent
Description

Cronos Group is a global cannabinoid operator with branded consumer products and a strategic partnership with a major pharma for cannabinoid therapeutic R&D. Relevant as a broad incumbent with pharma ambitions in the same therapeutic-category landscape Fiberlab targets.

TypeDirect peer
Description

CV Sciences develops and sells pharmaceutical-grade CBD products (e.g., its PlusCBDOil brand) with a GRAS-pending, cGMP-manufactured positioning. It is comparable to Fiberlab in its focus on pharmaceutical-grade, third-party-tested cannabinoid inputs over commodity-grade market positioning.

TypeBroad incumbent
Description

Jazz Pharmaceuticals acquired GW Pharmaceuticals, gaining FDA-approved cannabinoid drugs Epidiolex and Sativex. As the only large-cap pharma with approved cannabinoid therapeutics, Jazz is the reference incumbent for the pharmaceutical-grade cannabinoid specialty Fiberlab targets via the physician/compounding channel.

10Tilray Brands
TypeBroad incumbent
Description

Tilray is a large diversified cannabis operator with a pharmaceutical division (Tilray Medical) distributing GMP-produced cannabinoid products globally. It is comparable to Fiberlab as a broad incumbent with pharma-grade offerings across multiple international markets.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fiberlab

Pharmaceutical Cannabinoid Manufacturingfiberlab.io

Fiberlab Biotech is a U.S. manufacturer of pharmaceutical-grade cannabinoid acid isolates (THCA, CBDA, CBGA, CBCA, CBNA) at 99.9%+ purity and condition-specific compound formulas, distributed exclusively through licensed compounding pharmacies serving physician-directed clinical protocols.

What Fiberlab does

Fiberlab Biotech, founded in 2016 and privately held, is a U.S.-based manufacturer of pharmaceutical-grade cannabinoid acid isolates and condition-specific compound formulas, operating with 1–10 employees and a registered presence in Austin, TX. The company's core technology is a proprietary cryogenic (non-CO2) closed-loop extraction process combined with a six-step manufacturing workflow — extraction, winterization, decarboxylation, isolation, purification, and quality verification — designed to preserve cannabinoid acid integrity and achieve a stated 99.9%+ purity standard with zero residual solvents. All products undergo multi-method third-party verification, including HPLC-UV/LC-MS, GC-MS Headspace, ICP-MS, qPCR/Culture, and LC-MS/MS testing, with 100% COA coverage across the catalog.

The product portfolio is organized around five acid isolates (THCA, CBDA, CBGA, CBCA, CBNA) at 99.9%+ purity and four proprietary compound formulas — NeuroCalm (FC-N01), Serenity (FC-S02), Oncology Support (FC-O03), and Inflammation Protocol (FC-I04) — each blended for specific therapeutic indications including neurological disorders, chronic pain, PTSD, oncology support, and inflammation. Two delivery devices, a Cannabinoid Nasal Spray (10 mL, 100 doses) and a Cannabinoid Inhaler, extend the portfolio into rapid-onset pulmonary and intranasal administration.

Fiberlab generates revenue through physician-priced sales of its isolates, compound formulas, and delivery devices, distributed exclusively through a network of 6+ licensed compounding pharmacies across 4 states (AZ, CO, TN, TX). The go-to-market is sales-led and physician-directed, with inquiries routed through a clinical affairs team that provides same-day response to physicians and 1–5 business day response to pharmacies, patients, and researchers. Pricing is quote-based and not publicly disclosed; a 2026 strategic pivot and the launch of the CannapūrRx sub-brand signal an ongoing portfolio repositioning.

Fiberlab firmographics

Firmographics
Name
Fiberlab
Legal name
Fiberlab Biotech
Website
https://fiberlab.io
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
Fiberlab Biotech is a U.S. manufacturer of pharmaceutical-grade cannabinoid acid isolates (THCA, CBDA, CBGA, CBCA, CBNA) at 99.9%+ purity and condition-specific compound formulas, distributed exclusively through licensed compounding pharmacies serving physician-directed clinical protocols.
Ownership category
akta.pro rank

Fiberlab industry classification

Industry
Product category
Pharmaceutical Cannabinoid Manufacturing
NAICS
Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAJAO
Compounding Ingredient & API Distributors (Pharma Supply)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

Keywords

  • Pharmaceutical cannabinoid isolates
  • Cannabinoid compound formulas
  • Cryogenic extraction processing
  • Compounding pharmacy supply
  • Purity verified cannabinoids

Where Fiberlab is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Fiberlab business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical Cannabinoid Product Sales: Sale of pharmaceutical-grade cannabinoid isolates (THCA, CBDA, CBGA, CBCA, CBNA) and compound formulas through licensed compounding pharmacy partners. Physician pricing model with quote-based inquiry process.
  2. Clinical Consultation Services: Clinical affairs team provides support for physicians, pharmacies, patients, and researchers. Response times vary by inquiry type: physicians receive same-day response, others within 1-5 business days.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goCannabinoid Nasal Spray - 10mL, 100 doses
Unit PricingPay-as-you-goCannabinoid Inhaler - Pulmonary delivery
Unit PricingPay-as-you-goIndividual Cannabinoid Isolates - Crystalline powder
Unit PricingPay-as-you-goCompound Formulas - Condition-specific blends

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Fiberlab product offering

Product offering

Core offering

Fiberlab manufactures pharmaceutical-grade cannabinoid acid isolates (THCA, CBDA, CBGA, CBCA, CBNA) at 99.9%+ purity using a proprietary cryogenic non-CO2 extraction and six-step manufacturing process with multi-method third-party verification. The company also blends these isolates into four condition-specific compound formulas (NeuroCalm, Serenity, Oncology Support, Inflammation Protocol) and produces two delivery devices (nasal spray and pulmonary inhaler). All products are distributed exclusively through a physician-directed model via licensed compounding pharmacies across AZ, CO, TN, and TX.

Product overview

Fiberlab Biotech offers a portfolio of pharmaceutical-grade cannabinoid acid products built around five core isolate types (THCA, CBDA, CBGA, CBCA, CBNA) at 99.9%+ purity, supplemented by four proprietary compound formulas (NeuroCalm, Serenity, Oncology Support, Inflammation Protocol) that blend multiple isolates for specific therapeutic indications. The company also manufactures two delivery devices — a nasal spray and an inhaler — designed for rapid-onset cannabinoid delivery. All products are manufactured using cryogenic extraction and are distributed exclusively through a network of licensed compounding pharmacies.

Differentiator

Problem solved

Functional benefit

Brands

  • CannapūrRx: Pharmaceutical-grade cannabinoid brand offering isolates and compound formulas for clinical applications including neurological disorders, chronic pain, PTSD, oncology support, and inflammation.

Products and services

  • THCA Isolate Tetrahydrocannabinolic acid in its purest pharmaceutical form — a 99.9%+ pure crystalline powder isolate with neuroprotective, anti-inflammatory, and anti-nausea properties, precisely dosed for clinical micro-dosing protocols. Sold to licensed physicians and compounding pharmacies.
  • CBDA Isolate Cannabidiolic acid isolate at 99.9%+ purity featuring serotonin-modulating properties, formulated for patients managing anxiety, PTSD, and treatment-related nausea. Sold to licensed physicians and compounding pharmacies.
  • CBGA Isolate The 'mother cannabinoid' isolate at 99.9%+ purity, the biosynthetic precursor to all major cannabinoids, supporting metabolic function and serving as the foundation of compound formulas, with antibacterial properties. Sold to licensed physicians and compounding pharmacies.
  • CBCA Isolate Cannabichromenic acid isolate at 99.9%+ purity with research-supported roles in neurogenesis and antimicrobial activity, a key component in neurological disorder protocols. Sold to licensed physicians and compounding pharmacies.
  • CBNA Isolate Cannabinolic acid isolate at 99.9%+ purity with sedative and appetite-stimulating properties, integral to oncology support and chronic pain compound formulas. Sold to licensed physicians and compounding pharmacies.
  • NeuroCalm Formula (FC-N01) A precision-blended compound formula combining THCA, CBCA, and CBGA isolates, targeting neuroprotection and pain modulation for patients with epilepsy, MS, Parkinson's, and neuropathic pain. Sold to physicians and compounding pharmacies.
  • Serenity Formula (FC-S02) Compound formula combining serotonin-modulating CBDA with calming CBNA, designed for patients navigating PTSD and anxiety disorders. Sold to physicians and compounding pharmacies.
  • Oncology Support Formula (FC-O03) A comprehensive adjunct formula combining THCA, CBDA, CBNA, and CBGA for patients in active cancer treatment, addressing nausea, appetite loss, pain, and inflammation with a full-spectrum cannabinoid acid blend. Sold to physicians and compounding pharmacies.
  • Inflammation Protocol (FC-I04) Targeted anti-inflammatory formula combining THCA, CBCA, and CBGA for systemic and localized inflammation, suitable for autoimmune conditions, arthritis, and post-surgical recovery. Sold to physicians and compounding pharmacies.
  • Cannabinoid Nasal Spray Advanced nasal delivery device providing 99.9%+ pure THC for rapid systemic absorption with precision dosing. 10 mL container providing 100 doses, no artificial flavors, colors, or preservatives, manufactured in GMP-certified facilities. Sold at physician pricing via inquiry.
  • Cannabinoid Inhaler Pulmonary delivery device providing pharmaceutical-grade 99.9%+ pure THC for targeted, fast-acting relief directly to the respiratory system with no combustion and no solvents. Sold at physician pricing via inquiry.

Quantifiable outcome

  • 99.9%+ pharmaceutical purity achieved across all cannabinoid isolates
  • +3 more outcomes

Companies that use Fiberlab

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Fiberlab technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Fiberlab partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core.

  • Austin Compounding PharmacycoreChannel Partner/ Reseller/ DistributorLicensed compounding pharmacy in Austin, TX (1200 S Lamar Blvd). Dispenses THCA, CBDA, CBGA isolates and NeuroCalm, Serenity compound formulas. Accepting new patients. Hours: Mon-Fri 9am-6pm, Sat 10am-3pm.
  • Houston Medical CompounderscoreChannel Partner/ Reseller/ DistributorLicensed compounding pharmacy in Houston, TX (4500 Bissonnet St). Dispenses THCA, CBCA, CBNA isolates and Oncology Support, Inflammation Protocol formulas. Accepting new patients. Hours: Mon-Fri 8am-7pm, Sat 9am-4pm.
  • Dallas Precision PharmacycoreChannel Partner/ Reseller/ DistributorLicensed compounding pharmacy in Dallas, TX (6750 Hillcrest Ave). Dispenses CBDA, CBGA isolates and Serenity, NeuroCalm compound formulas. Accepting new patients. Hours: Mon-Fri 9am-5:30pm.
  • Denver Integrative CompoundingcoreChannel Partner/ Reseller/ DistributorLicensed compounding pharmacy in Denver, CO (2100 E Colfax Ave). Dispenses all five isolates (THCA, CBDA, CBCA, CBNA, CBGA) and all four compound formulas. Accepting new patients. Hours: Mon-Fri 8:30am-6pm, Sat 10am-2pm.
  • Phoenix Clinical PharmacycoreChannel Partner/ Reseller/ DistributorLicensed compounding pharmacy in Phoenix, AZ (3300 N Central Ave). Dispenses THCA, CBGA isolates and Inflammation Protocol, Oncology Support formulas. Currently on waitlist. Hours: Mon-Fri 9am-6pm.
  • Nashville Compounding CentercoreChannel Partner/ Reseller/ DistributorLicensed compounding pharmacy in Nashville, TN (1800 Church St). Dispenses CBDA, CBNA isolates and Serenity, NeuroCalm compound formulas. Accepting new patients. Hours: Mon-Fri 9am-5pm.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Fiberlab competitors and assessment

Company assessment

Direct peers

  • Charlotte's Web Holdings: Charlotte's Web makes proprietary hemp-derived cannabinoid extracts targeting specific wellness and clinical use cases (sleep, calm, recovery) with branded product lines. Its vertically integrated cultivation-to-extract model and indication-focused product framing parallels Fiberlab's condition-specific compound formulas.
  • Elixinol Wellness: Elixinol produces premium, third-party-tested hemp-derived CBD oils and capsules for both practitioner and consumer channels. Comparable to Fiberlab as a smaller, quality-focused cannabinoid producer targeting health professional and pharmacy distribution.
  • Medical Marijuana Inc. Medical Marijuana Inc. operates a portfolio of hemp-derived CBD and cannabinoid brands including HempMeds and Kannaway, with a strong physician/direct-selling channel orientation. Comparable to Fiberlab in the niche of smaller, specialist cannabinoid companies building branded product portfolios around clinical/endorsement positioning.
  • MediPharm Labs: MediPharm Labs is a Canadian B2B manufacturer of pharmaceutical-grade cannabinoid APIs, extracts, and concentrates supplied to other producers and clinicians. Like Fiberlab, it focuses on wholesale purified inputs rather than retail consumer products, making it a directly comparable pharma-grade cannabinoid API supplier.
  • CV Sciences: CV Sciences develops and sells pharmaceutical-grade CBD products (e.g., its PlusCBDOil brand) with a GRAS-pending, cGMP-manufactured positioning. It is comparable to Fiberlab in its focus on pharmaceutical-grade, third-party-tested cannabinoid inputs over commodity-grade market positioning.

Broad incumbents

  • Aurora Cannabis: Aurora Cannabis operates a vertically integrated cannabinoid platform including GMP-certified production and medical cannabis distribution across multiple countries. Its broad medical/recreational footprint and GMP positioning make it a useful incumbent benchmark for Fiberlab's physician-channel ambitions.
  • Canopy Growth: Canopy Growth produces both medical and consumer cannabinoid products through brands like Spectrum Therapeutics, with strong GMP and pharmaceutical partnerships. Comparable to Fiberlab as a broad incumbent serving a physician/cannabinoid-medicine channel at meaningful scale.
  • Cronos Group: Cronos Group is a global cannabinoid operator with branded consumer products and a strategic partnership with a major pharma for cannabinoid therapeutic R&D. Relevant as a broad incumbent with pharma ambitions in the same therapeutic-category landscape Fiberlab targets.
  • Jazz Pharmaceuticals: Jazz Pharmaceuticals acquired GW Pharmaceuticals, gaining FDA-approved cannabinoid drugs Epidiolex and Sativex. As the only large-cap pharma with approved cannabinoid therapeutics, Jazz is the reference incumbent for the pharmaceutical-grade cannabinoid specialty Fiberlab targets via the physician/compounding channel.
  • Tilray Brands: Tilray is a large diversified cannabis operator with a pharmaceutical division (Tilray Medical) distributing GMP-produced cannabinoid products globally. It is comparable to Fiberlab as a broad incumbent with pharma-grade offerings across multiple international markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Fiberlab social profiles

Digital presence

Fiberlab financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fiberlab leadership team

Management profile

Number of profiles

Fiberlab funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fiberlab M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fiberlab

What does Fiberlab do?

Fiberlab manufactures pharmaceutical-grade cannabinoid acid isolates (THCA, CBDA, CBGA, CBCA, CBNA) at 99.9%+ purity using a proprietary cryogenic non-CO2 extraction and six-step manufacturing process with multi-method third-party verification. The company also blends these isolates into four condition-specific compound formulas (NeuroCalm, Serenity, Oncology Support, Inflammation Protocol) and produces two delivery devices (nasal spray and pulmonary inhaler). All products are distributed exclusively through a physician-directed model via licensed compounding pharmacies across AZ, CO, TN, and TX.

Is Fiberlab a public or private company?

Fiberlab is a private company. It is classified as unknown and is currently operating.

When was Fiberlab founded?

Fiberlab was founded in 2016. It employs 1 to 10 people.

Where is Fiberlab based?

Fiberlab is headquartered in Austin, United States, in the North America region.

How does Fiberlab make money?

Two revenue lines are on record. Pharmaceutical Cannabinoid Product Sales are the primary driver. The others are clinical Consultation Services.

Who are Fiberlab's main competitors?

Direct peers on record are Charlotte's Web Holdings, Elixinol Wellness, Medical Marijuana Inc., MediPharm Labs and CV Sciences. Broad incumbents are Aurora Cannabis, Canopy Growth, Cronos Group, Jazz Pharmaceuticals and Tilray Brands.

Does Fiberlab have an API?

No public API is recorded for Fiberlab.

What industry is Fiberlab in?

Fiberlab's product category is Pharmaceutical Cannabinoid Manufacturing. Its primary akta.pro industry code is HLAIAJAO, Compounding Ingredient & API Distributors (Pharma Supply). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales